444 related articles for article (PubMed ID: 17080380)
1. Staphylococcus aureus bacteremia in older adults: predictors of 7-day mortality and infection with a methicillin-resistant strain.
Bader MS
Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1219-25. PubMed ID: 17080380
[TBL] [Abstract][Full Text] [Related]
2. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity.
Lesens O; Methlin C; Hansmann Y; Remy V; Martinot M; Bergin C; Meyer P; Christmann D
Infect Control Hosp Epidemiol; 2003 Dec; 24(12):890-6. PubMed ID: 14700403
[TBL] [Abstract][Full Text] [Related]
3. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus.
Shurland S; Zhan M; Bradham DD; Roghmann MC
Infect Control Hosp Epidemiol; 2007 Mar; 28(3):273-9. PubMed ID: 17326017
[TBL] [Abstract][Full Text] [Related]
4. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.
Yaw LK; Robinson JO; Ho KM
Lancet Infect Dis; 2014 Oct; 14(10):967-75. PubMed ID: 25185461
[TBL] [Abstract][Full Text] [Related]
5. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus aureus bloodstream infections: the association between age and mortality and functional status.
Malani PN; Rana MM; Banerjee M; Bradley SF
J Am Geriatr Soc; 2008 Aug; 56(8):1485-9. PubMed ID: 18662207
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.
Bassetti M; Trecarichi EM; Mesini A; Spanu T; Giacobbe DR; Rossi M; Shenone E; Pascale GD; Molinari MP; Cauda R; Viscoli C; Tumbarello M
Clin Microbiol Infect; 2012 Sep; 18(9):862-9. PubMed ID: 21999245
[TBL] [Abstract][Full Text] [Related]
8. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia.
Reed SD; Friedman JY; Engemann JJ; Griffiths RI; Anstrom KJ; Kaye KS; Stryjewski ME; Szczech LA; Reller LB; Corey GR; Schulman KA; Fowler VG
Infect Control Hosp Epidemiol; 2005 Feb; 26(2):175-83. PubMed ID: 15756889
[TBL] [Abstract][Full Text] [Related]
9. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges.
Cosgrove SE; Qi Y; Kaye KS; Harbarth S; Karchmer AW; Carmeli Y
Infect Control Hosp Epidemiol; 2005 Feb; 26(2):166-74. PubMed ID: 15756888
[TBL] [Abstract][Full Text] [Related]
10. Pediatric and neonatal Staphylococcus aureus bacteremia: epidemiology, risk factors, and outcome.
Burke RE; Halpern MS; Baron EJ; Gutierrez K
Infect Control Hosp Epidemiol; 2009 Jul; 30(7):636-44. PubMed ID: 19496643
[TBL] [Abstract][Full Text] [Related]
11. Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology.
Schreiber MP; Chan CM; Shorr AF
J Crit Care; 2011 Aug; 26(4):395-401. PubMed ID: 21036521
[TBL] [Abstract][Full Text] [Related]
12. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
Laupland KB; Ross T; Gregson DB
J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
[TBL] [Abstract][Full Text] [Related]
14. Community-acquired methicillin-resistant Staphylococcus aureus bacteremia in Taiwan: risk factors for acquisition, clinical features and outcome.
Lin JC; Yeh KM; Peng MY; Chang FY
J Microbiol Immunol Infect; 2004 Feb; 37(1):24-8. PubMed ID: 15060683
[TBL] [Abstract][Full Text] [Related]
15. Active surveillance to determine the impact of methicillin-resistant Staphylococcus aureus colonization on patients in intensive care units of a Veterans Affairs Medical Center.
Patel M; Weinheimer JD; Waites KB; Baddley JW
Infect Control Hosp Epidemiol; 2008 Jun; 29(6):503-9. PubMed ID: 18510459
[TBL] [Abstract][Full Text] [Related]
16. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.
Chang FY; MacDonald BB; Peacock JE; Musher DM; Triplett P; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
Medicine (Baltimore); 2003 Sep; 82(5):322-32. PubMed ID: 14530781
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.
Lin SH; Liao WH; Lai CC; Liao CH; Tan CK; Wang CY; Huang YT; Hsueh PR
J Antimicrob Chemother; 2010 Aug; 65(8):1792-8. PubMed ID: 20511366
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of community-acquired Staphylococcus aureus bacteremia.
Chi CY; Wong WW; Fung CP; Yu KW; Liu CY
J Microbiol Immunol Infect; 2004 Feb; 37(1):16-23. PubMed ID: 15060682
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors of meticillin resistance among patients with Staphylococcus aureus bloodstream infections at hospital admission.
Manzur A; Vidal M; Pujol M; Cisnal M; Hornero A; Masuet C; Peña C; Gudiol F; Ariza J
J Hosp Infect; 2007 Jun; 66(2):135-41. PubMed ID: 17513007
[TBL] [Abstract][Full Text] [Related]
20. Changing epidemiology of community-onset methicillin-resistant Staphylococcus aureus bacteremia.
Johnson LB; Bhan A; Pawlak J; Manzor O; Saravolatz LD
Infect Control Hosp Epidemiol; 2003 Jun; 24(6):431-5. PubMed ID: 12828320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
